News

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S. market in the third quarter of 2025. International rollouts are expected to ...
An inexpensive pill for treating HIV could become an alternative to injections for diabetic eye disease, a small study ...
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...
Bayer announces EMA committee recommends label extension approval for Eylea 8 mg: Berlin Monday, May 26, 2025, 17:00 Hrs [IST] Bayer announced that the Committee for Medicinal Pro ...
The Seoul Central District Court ruled against Regeneron, which had sought to block Samsung Bioepis from producing and selling a biosimilar referencing the US firm’s Eylea, a blockbuster medicine used ...
Detailed price information for Roche Holdings Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.
German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of ...
BAYRY's Eylea 8 mg gets CHMP nod in EU, promising 6-month dosing for nAMD and DME with strong 3-year efficacy and safety data ...
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
The impact varied by procedure type, with minimal impact on injection eye drugs and the greatest impact on laser peripheral iridotomy. From least to most impact, the procedures were 2: This study ...
(WJW) – Multiple over-the-counter eye care products are being voluntarily recalled nationwide after a U.S. Food and Drug Administration audit revealed serious manufacturing violations.